vs

Side-by-side financial comparison of LANDSTAR SYSTEM INC (LSTR) and Zimmer Biomet (ZBH). Click either name above to swap in a different company.

Zimmer Biomet is the larger business by last-quarter revenue ($2.1B vs $1.2B, roughly 1.8× LANDSTAR SYSTEM INC). Zimmer Biomet runs the higher net margin — 11.4% vs 3.4%, a 8.1% gap on every dollar of revenue. On growth, Zimmer Biomet posted the faster year-over-year revenue change (9.3% vs 1.6%). Over the past eight quarters, Zimmer Biomet's revenue compounded faster (3.7% CAGR vs -2.2%).

Landstar System, Inc. is an American transportation services company specializing in logistics and, more specifically, third-party logistics. Landstar utilizes an extensive network of over 8,800 independent owner-operators, referred to internally as business capacity owners (BCOs), over 1,000 independent freight agents, and over 70,000 vetted carriers. Landstar provides services principally throughout the United States and to a lesser extent in Canada and between the U.S. and Canada, Mexico, ...

Zimmer Biomet Holdings, Inc. is a publicly traded American medical device company. It was founded in 1927 to produce aluminum splints. The firm is headquartered in Warsaw, Indiana, where it is part of the medical devices business cluster.

LSTR vs ZBH — Head-to-Head

Bigger by revenue
ZBH
ZBH
1.8× larger
ZBH
$2.1B
$1.2B
LSTR
Growing faster (revenue YoY)
ZBH
ZBH
+7.7% gap
ZBH
9.3%
1.6%
LSTR
Higher net margin
ZBH
ZBH
8.1% more per $
ZBH
11.4%
3.4%
LSTR
Faster 2-yr revenue CAGR
ZBH
ZBH
Annualised
ZBH
3.7%
-2.2%
LSTR

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
LSTR
LSTR
ZBH
ZBH
Revenue
$1.2B
$2.1B
Net Profit
$39.4M
$238.3M
Gross Margin
9.6%
64.6%
Operating Margin
4.5%
17.9%
Net Margin
3.4%
11.4%
Revenue YoY
1.6%
9.3%
Net Profit YoY
32.3%
30.5%
EPS (diluted)
$1.16
$1.22

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
LSTR
LSTR
ZBH
ZBH
Q1 26
$1.2B
$2.1B
Q4 25
$1.2B
$2.2B
Q3 25
$1.2B
$2.0B
Q2 25
$1.2B
$2.1B
Q1 25
$1.2B
$1.9B
Q4 24
$1.2B
$2.0B
Q3 24
$1.2B
$1.8B
Q2 24
$1.2B
$1.9B
Net Profit
LSTR
LSTR
ZBH
ZBH
Q1 26
$39.4M
$238.3M
Q4 25
$23.9M
$139.4M
Q3 25
$19.4M
$230.9M
Q2 25
$41.9M
$152.8M
Q1 25
$29.8M
$182.0M
Q4 24
$46.2M
$239.5M
Q3 24
$50.0M
$249.1M
Q2 24
$52.6M
$242.8M
Gross Margin
LSTR
LSTR
ZBH
ZBH
Q1 26
9.6%
64.6%
Q4 25
64.7%
Q3 25
72.1%
Q2 25
71.5%
Q1 25
71.2%
Q4 24
71.0%
Q3 24
70.5%
Q2 24
71.5%
Operating Margin
LSTR
LSTR
ZBH
ZBH
Q1 26
4.5%
17.9%
Q4 25
2.5%
6.9%
Q3 25
2.2%
17.6%
Q2 25
4.6%
14.4%
Q1 25
3.4%
15.3%
Q4 24
4.8%
19.2%
Q3 24
5.2%
15.3%
Q2 24
5.6%
18.1%
Net Margin
LSTR
LSTR
ZBH
ZBH
Q1 26
3.4%
11.4%
Q4 25
2.0%
6.2%
Q3 25
1.6%
11.5%
Q2 25
3.5%
7.4%
Q1 25
2.6%
9.5%
Q4 24
3.8%
11.8%
Q3 24
4.1%
13.7%
Q2 24
4.3%
12.5%
EPS (diluted)
LSTR
LSTR
ZBH
ZBH
Q1 26
$1.16
$1.22
Q4 25
$0.70
$0.71
Q3 25
$0.56
$1.16
Q2 25
$1.20
$0.77
Q1 25
$0.85
$0.91
Q4 24
$1.30
$1.18
Q3 24
$1.41
$1.23
Q2 24
$1.48
$1.18

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
LSTR
LSTR
ZBH
ZBH
Cash + ST InvestmentsLiquidity on hand
$411.0M
$424.2M
Total DebtLower is stronger
$26.1M
$7.5B
Stockholders' EquityBook value
$799.0M
$12.7B
Total Assets
$1.6B
$22.7B
Debt / EquityLower = less leverage
0.03×
0.59×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
LSTR
LSTR
ZBH
ZBH
Q1 26
$411.0M
$424.2M
Q4 25
$452.2M
$591.9M
Q3 25
$434.4M
$1.3B
Q2 25
$426.2M
$556.9M
Q1 25
$473.4M
$1.4B
Q4 24
$566.6M
$525.5M
Q3 24
$531.3M
$569.0M
Q2 24
$504.0M
$420.1M
Total Debt
LSTR
LSTR
ZBH
ZBH
Q1 26
$26.1M
$7.5B
Q4 25
$0
Q3 25
$0
Q2 25
$0
Q1 25
$0
Q4 24
$0
Q3 24
$0
Q2 24
$0
Stockholders' Equity
LSTR
LSTR
ZBH
ZBH
Q1 26
$799.0M
$12.7B
Q4 25
$795.7M
$12.7B
Q3 25
$888.7M
$12.8B
Q2 25
$921.8M
$12.5B
Q1 25
$930.8M
$12.4B
Q4 24
$972.4M
$12.5B
Q3 24
$1.0B
$12.4B
Q2 24
$1.0B
$12.7B
Total Assets
LSTR
LSTR
ZBH
ZBH
Q1 26
$1.6B
$22.7B
Q4 25
$1.6B
$23.1B
Q3 25
$1.7B
$23.5B
Q2 25
$1.7B
$22.9B
Q1 25
$1.7B
$22.2B
Q4 24
$1.8B
$21.4B
Q3 24
$1.8B
$21.7B
Q2 24
$1.8B
$21.5B
Debt / Equity
LSTR
LSTR
ZBH
ZBH
Q1 26
0.03×
0.59×
Q4 25
0.00×
Q3 25
0.00×
Q2 25
0.00×
Q1 25
0.00×
Q4 24
0.00×
Q3 24
0.00×
Q2 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
LSTR
LSTR
ZBH
ZBH
Operating Cash FlowLast quarter
$359.4M
Free Cash FlowOCF − Capex
$245.9M
FCF MarginFCF / Revenue
11.8%
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
1.51×
TTM Free Cash FlowTrailing 4 quarters
$1.4B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
LSTR
LSTR
ZBH
ZBH
Q1 26
$359.4M
Q4 25
$72.7M
$517.4M
Q3 25
$89.3M
$418.7M
Q2 25
$7.1M
$378.2M
Q1 25
$55.7M
$382.8M
Q4 24
$61.1M
$506.3M
Q3 24
$83.1M
$395.7M
Q2 24
$48.1M
$369.4M
Free Cash Flow
LSTR
LSTR
ZBH
ZBH
Q1 26
$245.9M
Q4 25
$70.5M
$442.6M
Q3 25
$86.0M
$363.7M
Q2 25
$4.7M
$328.1M
Q1 25
$53.8M
$338.2M
Q4 24
$54.4M
$454.8M
Q3 24
$75.6M
$351.2M
Q2 24
$40.6M
$316.7M
FCF Margin
LSTR
LSTR
ZBH
ZBH
Q1 26
11.8%
Q4 25
6.0%
19.7%
Q3 25
7.1%
18.2%
Q2 25
0.4%
15.8%
Q1 25
4.7%
17.7%
Q4 24
4.5%
22.5%
Q3 24
6.2%
19.3%
Q2 24
3.3%
16.3%
Capex Intensity
LSTR
LSTR
ZBH
ZBH
Q1 26
Q4 25
0.2%
3.3%
Q3 25
0.3%
2.7%
Q2 25
0.2%
2.4%
Q1 25
0.2%
2.3%
Q4 24
0.6%
2.5%
Q3 24
0.6%
2.4%
Q2 24
0.6%
2.7%
Cash Conversion
LSTR
LSTR
ZBH
ZBH
Q1 26
1.51×
Q4 25
3.04×
3.71×
Q3 25
4.61×
1.81×
Q2 25
0.17×
2.48×
Q1 25
1.87×
2.10×
Q4 24
1.32×
2.11×
Q3 24
1.66×
1.59×
Q2 24
0.91×
1.52×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons